Summary
Definition
History and exam
Key diagnostic factors
- presença de fatores de risco
- exposição à digoxina
- sintomas gastrointestinais
- sintomas do sistema nervoso central
- sintomas visuais
Other diagnostic factors
- probabilidade de suicídio
- sintomas cardiovasculares
Risk factors
- idade >55 anos
- clearance renal diminuído
- hipercalemia (>5.0 milimoles/L)
- hipocalemia (<3.0 a 3.5 milimoles/L)
- uso concomitante de medicamentos específicos
- hipomagnesemia
- hipercalcemia
- hipotireoidismo
Diagnostic investigations
1st investigations to order
- eletrocardiograma (ECG)
- concentração sérica de digoxina
- nível de potássio sérico
- nível de magnésio sérico
- creatinina sérica e ureia
Treatment algorithm
ingestão aguda, toxicidade baixa a moderada
ingestão crônica, toxicidade baixa a moderada
toxicidade grave ou comprometimento hemodinâmico (toxicidade aguda ou crônica)
toxicidade aguda ou crônica após início do tratamento
Contributors
Authors
Scott Phillips, MD
Associate Clinical Professor of Medicine
Department of Clinical Pharmacology and Toxicology
University of Colorado
Denver
CO
Associate Medical Director
Washington Poison Center
Seattle
WA
Disclosures
SP declares that he has no competing interests.
Acknowledgements
Dr Scott Phillips would like to gratefully acknowledge Dr Oladapo A. Odujube and Dr Robert S. Hoffman, previous contributors to this topic.
Disclosures
OAO and RSH declare that they have no competing interests.
Peer reviewers
Edward W. Boyer, MD
University of Massachusetts Medical School
Worcester
MA
Disclosures
EWB declares that he has no competing interests.
Ruben Thanacoody, MD, FRCP(Edin)
Consultant Physician and Clinical Toxicologist
National Poisons Information Service (Newcastle)
Newcastle-upon-Tyne
UK
Disclosures
RT declares that he has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
References
Key articles
Gheorghiade M, van Veldhuisen DJ, Colucci WS. Contemporary use of digoxin in the management of cardiovascular disorders. Circulation. 2006 May 30;113(21):2556-64. Abstract
Smith TW, Haber E, Yeatman L, et al. Reversal of advanced digoxin intoxication with Fab fragments of digoxin-specific antibodies. N Engl J Med. 1976 Apr 8;294(15):797-800. Abstract
Smith TW, Butler VP Jr, Haber E, et al. Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases. N Engl J Med. 1982 Nov 25;307(22):1357-62. Abstract
Bismuth C, Gaultier M, Conso F, et al. Hyperkalemia in acute digitalis poisoning: prognostic significance and therapeutic implications. Clin Toxicol. 1973;6(2):153-62. Abstract
Taboulet P, Baud FJ, Bismuth C, et al. Acute digitalis intoxication--is pacing still appropriate? J Toxicol Clin Toxicol. 1993;31(2):261-73. Abstract
Reference articles
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

Differentials
- Toxicidade por betabloqueador
- Toxicidade por bloqueador de canais de cálcio
- Toxicidade por clonidina
More DifferentialsGuidelines
- 2018 ACC/AHA/HRS Guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay
- Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning
More GuidelinesPatient information
Insuficiência cardíaca: como posso me ajudar?
Insuficiência cardíaca
More Patient informationLog in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer